from what i gather, this was biontech's primary aim before they suddenly were thrust into the vaccine business. i think the idea was not just cancer therapies,

from what i gather, this was biontech's primary aim before they suddenly were thrust into the vaccine business. i think the idea was not just cancer therapies, but personalized cancer therapies with custom mrnas derived from biopsy material.